Overcoming Key Challenges of bsAb Cell Line Development

Successful manufacturing of bispecific antibodies (bsAbs) requires not only high expression levels, but also precise assembly of multiple antibody chains to generate the desired product while minimizing chain mismatches, misassembled species, and other product-related impurities. Achieving the optimal balance between productivity and product quality remains a critical hurdle in CHO-based expression systems.

Current cell line engineering approaches typically rely on either multi-plasmid or single-plasmid expression strategies. Multi-plasmid systems provide flexibility by enabling adjustment of plasmid ratios to influence chain expression and assembly but require extensive optimization. Single-plasmid approaches simplify transfection and selection workflows but can limit flexibility in balancing expression of multiple chains.

Just – Evotec Biologics: Integrated Solutions for complex bsAbs expression, assembly and manufacturability

1. Rapid Design Space Exploration

Our high-throughput transfection platform enables the generation of multiple stable pools in parallel, supporting up to 25 transfections simultaneously. This capability allows rapid evaluation of different plasmid ratios, vector configurations, and transfection conditions to identify optimal expression strategies for complex multi-chain molecules.

Two plasmids, each carrying a heavy chain (HC) and a light chain (LC) gene and a different selection marker (G and S). Together they are expressed as a bispecific antibody made from both heavy and light chain pairs.

2. Comprehensive Product Quality Assessment

To enable early identification of the most promising pools and expression systems with correct chain pairing and assembly, we employ high-throughput chromatographic and electrophoretic analytical methods to quickly detect chain mismatches, misassembled species, and other  product-related impurities. 

3. Inducible Hosts for Challenging Molecules

For difficult-to-express bispecific antibodies, our inducible host cell line provides additional control over recombinant protein production, helping improve cell viability, productivity, and overall manufacturability.

4. Simplified Multi-Chain Expression

Our proprietary Split-GS vector system enables expression of complex multi-chain antibody formats while utilizing  a single GS selection strategy, reducing the need for additional antibiotic selection. 

Workflow for stable pool generation: cells are transfected with different plasmids, 25 transfections per plate, and selected to create stable pools. These are then used for a 10-day fed-batch production run at plate scale.

5. Manufacturing-Ready Process Solutions

Beyond cell line development, Just - Evotec Biologics has demonstrated the successful application of perfusion-based intensified manufacturing to produce bispecific antibodies at high yield and high quality, supporting efficient scale-up from development through commercial manufacturing.

Learn More About Our Cell Line Development Solutions

Image of molecules in motion

Cell Line Development Solutions

The J.CHO High Expression System combines extremely high titers with the best product quality allowing our partners to achieve Cost of Goods Manufactured (COGM) below $50/g using our continuous manufacturing platform.

Learn more

Therapeutic Areas:

Scientific Topics:

Resource Types: